ArrayScreen will exploit 'microarray' or '2DNA Chip' technology and the information provided by the Human Genome Project to develop revolutionary diagnostic tests to predict a variety of medical conditions such as cardiovascular disease.

To provide a software solution for in silico drug discovery and prediction of drug side effects. Ccnet exploit the explosion of post-genomic data produced by high-throughput technologies such as DNA microarrays and portein chips.

GEO has developed a novel, in-situ testing technique applicable to several niche construction quality control (CQC testing market, estimated at over 35m pa) within the rapidly growing environmental industry.

Schmode's first product, the Light Tile, will make the surfaces of a room glow. As the technology develops, surfaces will change colour. Schmode will offer the first off-the-shelf electroluminescent product for designers or commercial and personal spaces.

Collection and log-term storage of umbilical cord blood stem cells for the benefit of the newborn child and their family. Additional business activities will include viral screening and tissue-typing (genetic identification) of the colleced stem cells.